Investigative Urology - Results from #6840

REVIEW UroToday

T1G3 high-risk NMIBC (non-muscle invasive bladder cancer): Conservative treatment versus immediate cystectomy - Abstract April 18, 2011

Cytotoxic effect of the red beetroot (Beta vulgaris L.) extract compared to doxorubicin (Adriamycin) in the human prostate (PC-3) and breast (MCF-7) cancer cell lines - Abstract April 15, 2011

The effect of tobacco, XPC, ERCC2 and ERCC5 genetic variants in bladder cancer development - Abstract April 13, 2011

Association of KLK3 (PSA) genetic variants with prostate cancer risk and PSA levels - Abstract April 12, 2011

Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma - Abstract April 12, 2011

Evidence of abnormal tyrosine phosphorylated proteins in the urine of patients with bladder cancer: The road toward a new diagnostic tool? - Abstract April 11, 2011

Germline CAG repeat length of the androgen receptor and time to progression in patients with prostate cancer treated with androgen deprivation therapy - Abstract April 8, 2011

Cysteine-rich secretory protein 3 and β-microseminoprotein on prostate cancer needle biopsies do not have predictive value for subsequent prostatectomy outcome - Abstract April 8, 2011

Lycopene enhances docetaxel's effect in castration-resistant prostate cancer associated with insulin-like growth factor I receptor levels - Abstract April 7, 2011

Evaluation of HER2 protein overexpression in non-muscle invasive bladder cancer with emphasis on tumour grade and recurrence - Abstract April 7, 2011

Effects of mTOR inhibitor everolimus (RAD001) on bladder cancer cells - Abstract April 6, 2011

Effects of increasing carbon nanofiber density in polyurethane composites for inhibiting bladder cancer cell functions - Abstract April 6, 2011

Apoptosis gene polymorphisms and risk of prostate cancer: A hospital-based study of German patients treated with brachytherapy - Abstract April 4, 2011

A phase II study of lapatinib, a dual EGFR and HER-2 tyrosine kinase inhibitor, in patients with castration-resistant prostate cancer - Abstract April 4, 2011

miR-221 is down-regulated in TMPRSS2:ERG fusion-positive prostate cancer - Abstract March 30, 2011

PTEN deletion and heme oxygenase-1 overexpression cooperate in prostate cancer progression and are associated with adverse clinical outcome - Abstract March 30, 2011

Genetic variants in urinary bladder cancer: Collective power of the "wimp SNPs - Abstract March 28, 2011

Prostate cancer-derived angiogenin stimulates the invasion of prostate fibroblasts - Abstract March 24, 2011

Analysis of XMRV integration sites from human prostate cancer tissues suggests PCR contamination rather than genuine human infection - Abstract March 24, 2011

Combination of adjuvant hormonal and radiation therapy significantly prolongs survival of patients with pT2-4 pN+ prostate cancer: Results of a matched analysis - Abstract March 24, 2011

Page 343 of 346